top of page

Publications
Communicating Evidence
Year | Title | Authors | Journal / Meeting |
|---|---|---|---|
2014 | Improving Access to Shared Decision Making for Latin Americans with Inadequately Controlled Type 2 Diabetes Mellitus | Davidson J, Allende-Vigo M, Aguilar R, Bailey R, Martin S, Shillington AC | AACE 23rd Annual Scientific and Clinical Congress |
2014 | Shared Decision-Making and a Patient Decision Aid for Inadequately Controlled Type 2 Diabetes Mellitus | Shillington AC, Col N, Bailey RA, Martin S | American Association of Diabetes Educators Annual Meeting |
2014 | The AbobotulinumtoxinA Economic Evaluation Program (DEEP): A Cost Analysis Of Cervical Dystonia (CD) Treatment Switch From OnabotulinumtoxinA (Botulinum Toxin A [ONA]) To AbobotulinumtoxinA ([ABO]) | Trosch RM, English ML, Shillington AC, Marchese D | Movement Disorders |
2014 | Cultural Adaptation of a Patient Decision Aid for Inadequately Controlled Type 2 Diabetes Mellitus in Latinos | Aguilar R, Davidson J, Allende-Vigo M, Bailey R, Shillington A | National Hispanic Medical Association Meeting 18th Annual Conference |
2014 | Systematic review of measures of personal recovery used in schizophrenia | Shillington A, Benson C, Frye C | Value in Health |
2013 | Prevalence of Axial SpA in US Rheumatology Practices: Assessment of ASAS Criteria vs Rheumatology Expert Clinical Diagnosis | Strand V, Rao SA, Shillington AC, Cifaldi MA, McGuire M, Ruderman EM | Arthritis Care Res |
2013 | Costs Associated with Intravenous Patient Controlled Analgesia (IV PCA) in US Hospitals | Schechter LN, Harshaw Q, Ernst FR, Krukas MR, Shillington AC | ISPOR 18th Annual International Meeting |
2013 | Middle-of-the-night hypnotic use in a large national health plan | Roth T, Berglund P, Shahly V, Shillington AC, Stephenson JJ, Kessler RC | J Clin Sleep Med |
2013 | Composite International Diagnostic Interview Screening Scales for DSM-IV Anxiety and Mood Disorders | Kessler RC, Calabrese JR, Farley PA, Gruber MJ, Jewell MA, Katon W, Keck PE, Nierenberg AA, Sampson NA, Shear MK, Shillington AS, Stein MB, Thase ME, Wittchen HU | Psychol Med |
2012 | Costs Associated with Breakthrough Pain in Cancer Patients | Narayana A, Katz N, Shillington AC, Stephenson JJ, Frye C, White RE, Portenoy R | American Academy of Pain Management |
2012 | Effect of Breakthrough Pain on Functional Status, Pain Interference, and Disability in Cancer Patients: Findings from the National Breakthrough Pain Survey | Narayana A, Katz N, Shillington AC, Stephenson JJ, Frye C, Portenoy R | American Society of Clinical Oncology Annual Meeting |
2012 | Prevalence Estimates of Axial Spondyloarthritis Among Patients in German Rheumatology Practices | Rao S, Cifaldi M, Joshi AD, Shillington A, McGuire M, Wittig B, Rudwaleit M | Ann Rheum Dis |
2012 | Prevalence Estimate and Gender Distribution of Axial Spondyloarthritis Among Patients in US Rheumatology Practices | Rao S, Shillington AC, Strand V, McGuire M, Cifaldi MA | Annual European Congress of Rheumatology |
2012 | The Associations of Insomnia with Costly Workplace Accidents and Errors: Results from the America Insomnia Survey | Shahly V, Berglund PA, Coulouvrat C, Fitzgerald T, Hajak G, Roth T, Shillington AC, Stephenson JJ, Walsh JK, Kessler RC | Arch Gen Psychiatry |
2012 | Current Practices in the Management of Chronic Myeloid Leukemia | Kantarjian HK, Larson, RA, Cortes JE, Deering KL, Mauro MJ | Clin Lymphoma Myeloma Leuk |
2012 | Validation of a Tool to Assess Medication Treatment Satisfaction in Patients with Type 2 Diabetes: the Diabetes Medication System Rating Questionnaire (DMSRQ) | Peyrot M, Harshaw Q, Shillington AC, Xu Y, Rubin RR | Diabet Med |
2012 | Costs Associated With Breakthrough Pain in Cancer Patients: Findings From the National Breakthrough Pain Survey | Narayana A, Katz N, Shillington AC, Stephenson JJ, Frye C, Portenoy R | ISPOR 18th Annual International Meeting |
2012 | Bleeding-associated Outcomes with Preoperative Clopidogrel Use in On- and Off-pump Coronary Artery Bypass | Berger, JS, Herout PM, Harshaw Q, Steinhubl SR, Frye CB, Becker RC | J Thromb Thrombolysis |
2012 | The National Breakthrough Pain Survey: Multivariate Predictors of Functional Status, Pain Interference, and Disability | Narayana A, Katz N, Shillington A, Stephenson J, Portenoy R | PAINWeek |
2012 | The Cost Associated with Breakthrough Pain: Findings from the National Breakthrough Pain Survey | Narayana A, Katz N, Shillington A, Stephenson J, Portenoy R | PAINWeek |
2012 | Breakthrough Pain and Its Association with Functional Status, Pain Interference, and Disability in Cancer Patients: Findings from the National Breakthrough Pain Study | Narayana A, Katz N, Shillington AC, Stephenson JJ, Frye C, White RE, Portenoy R | PAINWeek |
2012 | Insomnia, comorbidity, and risk of injury among insured Americans: results from the America Insomnia Survey | Kessler RC, Berglund PA, Coulouvrat C, Fitzgerald T, Hajak G, Roth T, Shahly V, Shillington AC, Stephenson JJ, Walsh JK | Sleep |
2012 | Insomnia, Cormorbidity, and Risk of Injury Among Insured Americans: Results from the America Insomnia Survey | Kessler RC, Berglund PA, Coulouvrat C, Fitzgerald T, Hajak G, Roth T, Shahly V, Shillington AC, Stephenson JJ, Walsh JK | Sleep Health and Safety |
2012 | The Associations of Insomnia with Costly Workplace Accidents and Errors: Results from the American Insomnia Survey | Shahly V, Berglund PA, Coulouvrat C, Fitzgerald T, Hajak G, Roth T, Shillington AC, Stephenson JJ, Walsh JK, Kessler RC | Sleep Health and Safety |
2011 | Implementation of a Web-Based Patient-Reported Outcomes Research Program | Costello K, Foley J, Miller D, Deering K | American Academy of Neurology |
2011 | Days-out-of-role associated with insomnia and comorbid conditions in the America Insomnia Survey | Hajak G, Petukhova M, Lakoma M, Coulouvrat C, Roth T, Sampson N, Shahly V, Shillington A, Stephenson J, Walsh J, Kessler RC | Biol Psychiatry |
2011 | Prevalence and perceived health associated with insomnia based on DSM-IV-TR; International Statistical Classification of Diseases and Related Health Problems, Tenth Revision; and Research Diagnostic Criteria/International Classification of Sleep Disorders, Second Edition criteria: results from the America Insomnia Survey | Roth T, Coulouvrat C, Hajak G, Lakoma MD, Sampson NA, Shahly V, Shillington AC, Stephenson JJ, Walsh JK, Kessler RC | Biol Psychiatry |
2011 | Creation of a Web-Based Multiple Sclerosis Patient-Reported Outcomes Research Program | Deering K, Agarwal S, Rajagopalan K, Harshaw Q, Shillington A, and the My MS Health Steering Committee | Value in Health |
2010 | Impact of Worsening Renal Function During Hospital Admission on Resource Utilization in Patients With Heart Failure | Herout P, Harshaw Q, Phatak H, Saka G, McNeill A, Wu D, Sazonov V, DeSagun R, Shirani J | Am J Cardiol |
2010 | Structure and Diagnosis of Adult Attention-Deficit/Hyperactivity Disorder: Analysis of Expanded Symptom Criteria from the Adult ADHD Clinical Diagnostic Scale | Kessler RC, Green JG, Adler LA, Barkley RA, Chatterji S, Faraone SV, Finkelman M, Greenhill LL, Gruber MJ, Jewell M, Russo LJ, Sampson NA, Van Brunt DL | Arch Gen Psychiatry |
2010 | Concordance of computerized self-report measures of DSM-IV-Tr, mood and anxiety disorders compared to gold standard clinical assessments in primary care | Kessker R, Farley A, Jewell M | ISPOR 15th Annual International Meeting |
2010 | Concordance of self-report measures of DSM-IV-TR, ICD-10, and RDC insomnia with standardized clinical assessments in the American Insomnia Survey (AIS) | Kessler R, Hajak G, Lakoma M | ISPOR 15th Annual International Meeting |
2010 | The American Insomnia Survey: an epidemiology study of insomnia prevalence and burden in a representative population | Kessler R, Coulouvrat C, Hajak G | ISPOR 15th Annual International Meeting |
2010 | Consensus and Discordance in the Management of Growth Hormone-Treated Patients: Results of a Knowledge, Attitudes, Beliefs, and Practices Survey | Miller BS, Shulman DI, Shillington A | Int J Pediatr Endocrinol |
2010 | The National Breakthrough Pain Survey (NBTPS): Design, Methodology, and Interim Results | Narayana A, Katz N, Shillington A | International Association for the Study of Pain 13th World Congress on Pain |
2010 | Dialysis health outcomes associated with pre-dialysis use of paricalcitol compared with no vitamin D receptor (VDR) activator treatment | Marx S, Frye C, Khan S | National Kidney Foundation |
2010 | Paricalcitol treatment in CKD patients with secondary hyperparathyroidism is associated with better health outcomes when compared with no vitamin D receptor [VDR] activator treatment | Sterz R, Frye C, Harshaw Q | National Kidney Foundation |
2010 | Comparative Effectiveness of Paricalcitol Versus Calcitriol Treatment in Chronic Kidney Disease [CKD] Patients with Secondary Hyperparathyroidism [SHPT] | Marx S, Frye C, Khan S, Harshaw Q, Audhya P, Deering K, Sterz R | National Kidney Foundation Spring Clinical Meeting Poster Presentation |
2010 | Reliability and Validity of the Brief Insomnia Questionnaire (BIQ) in the America Insomnia Survey (AIS) | Kessler R, Coulouvrat C, Hajak G, Lakoma MD, Roth T, Sampson N, Shahly V, Shillington A, Stephenson JJ, Walsh J, Zammit GK | Sleep |
2010 | Improved Resource Utilization Outcomes Associated with Predialysis Use of Paricalcitol for Secondary Hyperparathyroidism (SHPT) | Marx S, Frye C, Khan S, Harshaw Q, Audhya P, Deering K, Sterz R | Value in Health |
2009 | The American Insomnia Survey: an epidemiology study of insomnia in subjects with various comorbidities and/or conditions | Kessler RC, Coulouvrat C, Hajak G, Roth T, Sampson N, Shillington AC, Stephenson JJ, Walsh J | 3rd International Congress on Sleep Medicine of the World Association of Sleep Medicine and the 12th Brazilian Congress on Sleep Medicine |
2009 | All-Cause and Cardiovascular-Related Healthcare Resource Utilization and Costs Associated with Paricalcitol Use in Pre-Dialysis Chronic Kidney Disease (CKD) Patients with Secondary Hyperparathyroidism (SHPT) Compared with No Vitamin D Receptor Activator (VDRA) Therapy | Marx SE, Frye CB, Andress DL, Harshaw Q, Sterz R, Deering K, Audhya P | American Society of Nephrology's Renal Week |
2009 | Evaluation of Pre-Dialysis Doxercalciferol Use on Health Outcomes and Costs Compared to No Vitamin D Receptor Activator (VDRA) Treatment for Secondary Hyperparathyroidism (SHPT) | Harshaw Q, Andress DL, Marx SE, Frye CB, Sterz R, Deering K, Audhya P | American Society of Nephrology's Renal Week |
2009 | Impact of Pre-Dialysis Use of Calcitriol on Healthcare Resources Utilization and Costs Compared with No Vitamin D Receptor Activator (VDRA) Treatment for Secondary Hyperparathyroidism (SHPT) | Frye CB, Andress DL, Marx SE, Harshaw Q, Sterz R, Deering K, Audhya P | American Society of Nephrology's Renal Week |
2009 | Poorly Controlled Asthma and Health Service Utilization in New York in a Medicaid Managed Care Population | Silverman R, Reibman J, and the New York State Asthma Control and Co-morbidities Working Group | American Thoracic Society |
2009 | Discrepancies Between Knowledge, Attitudes and Beliefs and the Actual Practice (KABP) of Physicians who Care for Patients with Depression and/or Bipolar Disorder | Jewell M, Keck P, Golden WE, Brewster C, Farley AP, Harshaw Q | ISPOR 14th Annual International Meetin |
2009 | A Conceptual Analysis of the Costs of Care for a ?Major Bleed? in Studies of Antiplatelet and Antithrombotic Therapies | Harshaw Q, Frye CB, Hauch O | ISPOR 14th Annual International Meeting |
2009 | Improving data entry for post-marketing surveillance rhGH databases: Lessons from a knowledge (K), attitudes (A), beliefs (B) and practices (P) survey of Pediatric Endocrinologists | Kennedy J, Shulman D, Shillington A, Harshaw Q, Colgan K, Schwartz D, Kappy M, Wyatt D, Miller BS, Wilson D, McCormack L, Bakker B, Lippe B | Pediatric Endocrinology Nursing Society |
2009 | Comparing Outcomes Associated With Dose Manipulations of Enteric-Coated Mycophenolate Sodium Versus Mycophenolate Mofetil in Renal Transplant Recipients? | Cooper M, Deering KL, Slakey DP, Harshaw Q, Arcona S, McCann EL, Rasetto FA, Florman SS | Transplantation |
2008 | Switching HIV-infected, suppressed patients from ABC/3TC to FTC/TDF improves lipids - the SETTLE study | Gathe JC | 10th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV |
2008 | The STAndards for BipoLar Excellence (STABLE) Project: A bipolar disease quality improvement initiative to develop and validate evidence-based performance measures for national endorsement | Jewell MA, Golden W, Keck P | 13th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research |
2008 | Single Agent Therapy with Lopinavir/Ritonavir Suppresses HIV-1 Viral Replication in ARV Na?ve Patients: IMANI II ? 96 Week Final Results | Gathe JC, Yeh RF, Mayberry C, Nemecek J, Miguel B, Lipman BA, Fath MJ | 48th Annual ICAAC / IDSA 46th Annual Meeting |
2008 | Pharmacoeconomic analysis of bleeding complications and reoperation costs in patients with ACS receiving clopidogrel who require CABG surgery | Harshaw Q, Wygant GD, Hauch O, Berger JS, Frye CB, Becker RC | AHA 9th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke |
2008 | Impact of thienopyridines on bleeding complications with ACS patients requiring CABG surgery | Berger JS, Frye CB, Harshaw Q, Edwards FH, Steinhubl SR, Becker RC | American Heart Association Scientific Sessions |
2008 | Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysis | Berger JS, Frye CB, Harshaw Q, Edwards FH, Steinhubl SR, Becker RC | J Am Coll Cardiol |
2008 | Psychosocial Interventions as Adjunctive Therapy for Bipolar Disorder | Sachs GS | J Psychiatr Prac |
2008 | Collaborative Mental Health and Primary Care for Bipolar Disorder | Williams JW, Manning JS | J Psychiatr Pract |
2008 | Clinical and Economic Effects of Unrecognized or Inadequately Treated Bipolar Disorder | Keck PE, Kessler RC, Ross R | J Psychiatr Pract |
2008 | Development of Evidence-Based Performance Measures for Bipolar Disorder: Overview of Methodology | Golden WE, Hermann RC, Jewell M, Brewster C | J Psychiatr Pract |
2008 | The STABLE Project: Addressing the Gap Between Evidence and Practice for Bipolar Disorder | Golden WE, Keck PE, Sachs GS, Oldham JM, Brewster C, Ross R | J Psychiatr Pract |
2008 | The Recovery Concept: Clinician and Consumer Perspectives | Stotland NL, Mattson MG, Bergeson S | J Psychiatr Pract |
2008 | Overview of the STAndards for BipoLar Excellence (STABLE) Project | Brewster C | J Psychiatr Pract |
2008 | Quality Improvement in Psychiatry: Why Measures Matter | Oldham JM, Golden WE, Rosof BM | J Psychiatr Pract |
2008 | Consensus and discordance in treating recombinant human growth hormone (rhGH) treated patients: results of a knowledge (K), attitudes (A), beliefs (B) and practices (P) [KABP] survey | Miller BS, Shulman D, Shillington AC | Pediatric Academic Societies and Asian Society for Pediatric Research Joint Meeting |
2008 | Clopidogrel-associated bleeding and related complications in patients undergoing coronary artery bypass grafting | Pickard AS, Becker RC, Schumock GT, Frye CB | Pharmacotherapy |
2007 | Single agent therapy with lopinavir/ritonavir controls HIV-1 replication in the central nervous system | Yeh RF, Letendre S, Novak IS | 14th Conference on Retroviruses and Opportunistic Infections |
2007 | A comparison of adverse events and quality of life before and after switching from Kaletra? Soft-gel to Kaletra? Tablets in an African American cohort | Rawlings MK, McGhee TA, Casey-Bailey S, Pasley M | 2007 American Conference for the Treatment of HIV |
2007 | Performance indicators for bipolar disorder: development and feasibility testing | Williams JW, Golden W, Keck PE, Jewel M, Brewster C | 30th Annual Meeting of the Society of General Internal Medicine |
2007 | Linear growth and BMI during growth hormone treatment of children with craniopharyngioma compared to other organic growth hormone deficiencies: The National Cooperative Growth Study experience | Lustig R, Meacham L, Frane J, Frye C, Bakker B | 46th Annual Meeting of the European Society for Paediatric Endocrinology |
2007 | Single-agent Therapy with Lopinavir/ritonavir Suppresses Plasma HIV-1 Viral Replication in HIV-1 Na?ve Subjects: IMANI-2 48-Week Results | Gathe JC, Yeh RF, Mayberry C | 4th IAS Conference |
2007 | Success of a Comprehensive school-based asthma intervention on clinical markers and resource utilization for inner-city children with asthma in Chicago: the Mobile CARE Foundation's asthma management program | Patel B, Sheridan P, Detjen P | Journal of Asthma |
2006 | Tolerability and therapy preference of lopinavir/ritonavir (Kaletra) Soft-gel capsules and tablets as single agent in a cohort of HIV positive adult patients (IMANI-2) | Gathe JC, Lipman BA, Mayberry C, Miguel B, Nemecek J | 8th International Congress on Drug Therapy in HIV Infection |
2005 | Outbreak of catheter-associated Klebsiella oxytoca and Enterobacter cloacae bloodstream infections in an oncology chemotherapy center | Watson JT, Jones RC, Siston AM, Fernandez JR, Martin K, Beck E, Sokalski S, Jensen BJ, Arduino MJ, Srinivasan A, Gerber SI | Archives of Internal Medicin |
2005 | Antithrombotic therapy practices in US hospitals in an era of practice guidelines | Tapson VF, Hyers TM, Waldo AL | Archives of Internal Medicine |
2005 | Retrospective cohort study of granisetron administration for PONV prophylaxis and treatment | Shillington AC, Farley PA, Varkey JA, Dempsey C, Murdakes C | Hospital Pharmacy |
2005 | Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs | Caprini JA, Tapson VF, Hyers TM | Journal of Vascular Surgery |
2005 | Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation | Waldo AL, Becker RC, Tapson VF, Colgan KJ | Journal of the American College of Cardiology |
2004 | Oral capecitabine plus radiation therapy administered neoadjuvantly in the management of rectal cancer | Sharif A, Ajlouni M, Wollner I | 86th Annual Meeting of the American Radium Society |
2004 | The Long-term Outcomes of Sibutramine Effectiveness on Weight (LOSE Weight) Study: evaluating the role of drug therapy within a weight management program in a group-model health maintenance organization | Porter JA, Raebel MA, Conner DA | Am J Manag Care |
2004 | Disparities in antithrombotic management | Caprini JA, Ballard DJ, Becker RC | American Heart Association 5th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke |
2004 | Antiemetic effectiveness of ondansetron and granisetron in patients with breast cancer treated with cyclophosphamide | Dempsey CL, Coop AJ, Shillington AC, Farley PA, Eberhardt DR, O'Briant S | American Journal of Health-System Pharmacy |
2004 | Venous thromboembolism treatment: results of a national database | Caprini JA, Marchev D, Glase C | American Venous Forum |
2004 | The National Anticoagulation Benchmark and Outcomes Report (NABOR?): evidence of a significant difference between guidelines and actual practice | Tapson VF, Hyers TM, Becker RC, Waldo AL, Colgan KJ, Shillington AC | International Society for Pharmacoeconomics and Outcomes Research 9th Annual International Meeting |
2004 | A comparison of hepatitis C treatment and outcomes at academic, private and Veterans? Affairs treatment centers | Jensen DM, Cotler SJ, Lam H, Harb G, Shillington AC | Journal of Alimentary Pharmacology and Therapeutics |
2004 | Durable response of breast cancer leptomeningeal metastasis to capecitabine monotherapy: case report | Rogers LR, Remer SE, Sheela Tejwani S | Neuro-oncology |
2003 | A multicenter drug utilization evaluation program for Timentin? | Billeter M, Levato J, Waldrep T, Dempsey CL, Farley PA | ASHP Midyear Meeting |
2003 | Comparison of survival in patients with pulmonary hypertension associated with fenfluramine to patients with primary pulmonary hypertension | Rich S, Shillington AC, McLaughlin V | American Journal of Cardiology |
2003 | Management of community-acquired pneumonia in one hospital compared with a national benchmark database | Hampton N, Romie A, Clewell L, Hadzima S, Gerdes JM | Hospital Pharmacy |
2003 | Complete and sustained remission of refractory cervical cancer following a single cycle of capecitabine a case report | Hindenburg AA, Matthews L | International Journal of Gynecological Cancer |
2003 | Improvements in glycemic control in type 2 diabetes patients switched from sulfonylurea coadministered with metformin to glyburide-metformin tablets | Duckworth W, Marcelli M, Padden M | Journal of Managed Care Pharmacy |
2003 | Pyridoxine treatment and prevention of hand-and-foot syndrome in patients receiving capecitabine | Mortimer JE, Lauman MK, Tan B, Dempsey CL, Shillington AC, Hutchins KS | Journal of Oncology Pharmacy Practice |
2003 | 5-HT3 antiemetic use in breast cancer patients receiving cyclophosphamide: a multi-center practice evaluation | Coop AJ, Farley PA, Shillington AC, Dempsey CL, Colgan KC | MASCC/ISOO 15th International Symposium |
2003 | A descriptive practice evaluation of granisetron utilization in the management of postoperative nausea and vomiting | Shillington A, Dempsey C, Farley PA, Coop A, Eberhardt DR, Varkey JA | New York State Society of Anesthesia Annual Meeting |
2003 | Hormone-refractory prostate cancer responding to capecitabine ? | El-Rayes, BF ,Black CA, Ensley JF | Urology |
2002 | Improvements in glycemic control in type 2 diabetes patients switched from sulfonylurea co-administered with metformin to glyburide/metformin tablets | Duckworth W, Marcelli M, Roman F | Academy of Managed Care Pharmacy |
2002 | Prognosis of patients with primary pulmonary hypertension induced by fenfluramine diet pills | Rich S, Shillington A, McLaughlin VV | American Thoracic Society |
2002 | Survival in primary pulmonary hypertension: the impact of epoprostenol therapy | McLaughlin VV, Shillington A, Rich S | Circulation |
2002 | A single-institution experience with concurrent capecitabine and radiation therapy in gastrointestinal malignancies | Vaishampayan UN, Ben-Josef E, Philip PA | Int J Radiation Oncology Biology Physics |
2002 | Granisetron vs dolasetron for acute nausea and vomiting in high and moderately-high emetogenic chemotherapy | Tan M, Xu R, Seth R | MASCC/ISOO 14th International Symposium |
2001 | Chronic fatigue syndrome (CFS): pharmacoeconomic analysis of Ampligen? intervention | Shillington AC, Hilley H, Carter WA, Strayer DR | AACSF Annual Meeting |
bottom of page